RYTM — RHYTHM PHARMACEUTICALS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1649904 ·
Last close
$99.25
Market Cap
$6.81B
52W High
$115.92
52W Low
$79.40
ADV30
825,170
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 60,112,000 | 52,955,000 | -52,361,000 | -55,639,000 | 442,316,000 | 62,137,000 | 204,700,000 |
| Dec 2025 | 57,253,000 | 52,451,000 | -47,063,000 | -47,505,000 | 480,196,000 | 54,301,000 | 210,170,000 |
| Sep 2025 | 51,298,000 | 45,799,000 | -52,653,000 | -52,904,000 | 506,874,000 | 52,078,000 | 211,191,000 |
| Jun 2025 | 48,502,000 | 42,959,000 | -45,296,000 | -46,632,000 | 372,733,000 | 135,586,000 | 239,150,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-119,509,000
Investing CF
$-104,913,000
Financing CF
$180,064,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.13
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,407,516,000
Inventory
$28,651,000
Receivables
$34,192,000
ST Investments
$278,488,000
EBIT TTM
$-181,961,000
Pretax Income TTM
$-201,718,000
Interest Exp TTM
$19,757,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$217,164,992
EBITDA
$-196,166,000
Free Cash Flow
$-150,679,248
Enterprise Value
$6,688,254,464
Total Cash
$340,624,992
Total Debt
$112,308,000
Shares Out
68,593,574
Trailing EPS
$-3.13
Book Value
$1.80
ROE
-101.2%
ROA
-29.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 189,757,000 | -192,016,000 | -196,539,000 | 480,196,000 | 210,170,000 | — | -115,675,000 |
| Dec 2024 | 130,126,000 | -265,503,000 | -260,602,000 | 392,273,000 | 227,724,000 | — | -113,879,000 |
| Dec 2023 | 77,428,000 | -184,357,000 | -184,678,000 | 332,745,000 | 162,986,000 | — | -136,157,000 |
| Dec 2022 | 23,638,000 | -179,157,000 | -181,119,000 | 382,481,000 | 118,219,000 | — | -173,428,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.65
Max Pain — expiry 2027-01-15
max pain strike: $90.00 · spot: $99.25 · call oi: 1,294 · put oi: 431Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | $6.65B | $38.93 | — |
| MIRM | Mirum Pharmaceuticals, Inc. | $6.46B | $105.95 | — |
| BLTE | BELITE BIO, INC | $6.36B | $158.61 | — |
| ERAS | Erasca, Inc. | $6.30B | $18.15 | — |
| LQDA | Liquidia Corp | $7.48B | $84.11 | — |
News headlines (Yahoo Finance, 1h cache)
Could Anticipated Q2 Earnings Beat Amid Weaker Profitability Reframe Rhythm Pharmaceuticals’ Growth Story (RYTM)?
2026-07-28 18:07 · Yahoo
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
2026-07-28 14:00 · Yahoo
Here Are Monday’s Top Wall Street Analyst Research Calls: Alphabet, Clean Harbors, Ford, Huntington Bancshares, Rivian, Rocket Lab, Terawulf, Vale, Warner Bros. Discovery, and More
2026-07-27 11:46 · Yahoo
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
2026-07-21 12:00 · Yahoo
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
2026-07-08 21:07 · Yahoo
Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results?
2026-06-30 13:22 · Yahoo
Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?
2026-06-29 13:37 · Yahoo
Intel Stock and 3 Other Winners I Found Using Barchart’s High-Octane Stock Screener
2026-06-22 15:30 · Yahoo
Can Rhythm Pharmaceuticals (RYTM) ’s New Data Help Patients With a Rare Hunger Disorder?
2026-06-22 14:15 · Yahoo
Rhythm Pharmaceuticals posts long-term setmelanotide data for obesity
2026-06-16 15:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.